Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Fava

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Current Diabetes Reviews|November 1, 2014
Glucagon-like peptide 1 and the cardiovascular systemStephen Fava
Current Diabetes Reviews|April 22, 2014
Glycaemic control: a balancing act or a different approach?Stephen Fava
Expert Review of Cardiovascular Therapy|June 24, 2008
Role of postprandial hyperglycemia in cardiovascular diseaseStephen Fava
Diabetes Research and Clinical Practice|November 4, 2018
All-cause mortality in patients on sulphonylurea monotherapy compared to metformin monotherapy in a nation-wide cohortSascha Reiff, Stephen Fava
Acta Diabetologica|March 4, 2024
Association of body mass index and blood pressure variability with 10-year mortality and renal disease progression in type 2 diabetesStephen Fava, Sascha Reiff
Diabetes & Metabolic Syndrome|April 3, 2022
Does optimal HbA1c in diabetes differ according to drug treatment? An evaluation of national electronic database in MaltaSascha Reiff, Stephen Fava
Endocrine|April 28, 2022
Prenatal and early life factors and type 1 diabetesAlexia G Abela, Stephen Fava
Expert Review of Clinical Immunology|August 27, 2013
Does the level of bacterial exposure in early life impact the risk of Type 1 diabetes?Alexia-Giovanna Abela, Stephen Fava
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 14, 2012
Should diabetes still be considered a coronary artery disease equivalent?Caroline J Magri, Stephen Fava
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 1, 2019
Benefits and risks of testosterone therapy in older menCarol Cardona Attard, Stephen Fava
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Current Diabetes Reviews|November 1, 2014
Glucagon-like peptide 1 and the cardiovascular systemStephen Fava
Current Diabetes Reviews|April 22, 2014
Glycaemic control: a balancing act or a different approach?Stephen Fava
Expert Review of Cardiovascular Therapy|June 24, 2008
Role of postprandial hyperglycemia in cardiovascular diseaseStephen Fava
Diabetes Research and Clinical Practice|November 4, 2018
All-cause mortality in patients on sulphonylurea monotherapy compared to metformin monotherapy in a nation-wide cohortSascha Reiff, Stephen Fava
Acta Diabetologica|March 4, 2024
Association of body mass index and blood pressure variability with 10-year mortality and renal disease progression in type 2 diabetesStephen Fava, Sascha Reiff
Diabetes & Metabolic Syndrome|April 3, 2022
Does optimal HbA1c in diabetes differ according to drug treatment? An evaluation of national electronic database in MaltaSascha Reiff, Stephen Fava
Endocrine|April 28, 2022
Prenatal and early life factors and type 1 diabetesAlexia G Abela, Stephen Fava
Expert Review of Clinical Immunology|August 27, 2013
Does the level of bacterial exposure in early life impact the risk of Type 1 diabetes?Alexia-Giovanna Abela, Stephen Fava
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 14, 2012
Should diabetes still be considered a coronary artery disease equivalent?Caroline J Magri, Stephen Fava
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 1, 2019
Benefits and risks of testosterone therapy in older menCarol Cardona Attard, Stephen Fava
Pageof 8